Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
This is an open-label, non-randomized, multi-center trial designed to provide expanded access
of deferasirox to patients with congenital disorders of red blood cells and chronic iron
overload from blood transfusions who cannot adequately be treated with locally approved iron
chelators.